二氧化诱导的通用布鲁斯固定药物喷发:潜在致命副作用的案例报告
Consortium psychiatricum
|September 10, 2025
概括
二氧化物很少会导致泛型状固定药物喷发 (GBFDE),严重的皮肤反应. 这一案例强调了临床医生在开这款药物时需要监测患者是否有GBFDE.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 固定药物喷发 (FDE) 是一种皮肤不良药物反应.
- 泛型状固定药物喷发 (GBFDE) 是FDE的一个严重变体.
- 之前没有文献将二氧化与GBFDE联系起来.
研究的目的:
- 报告氧化和GBFDE之间的新兴关联.
- 提高临床医生对这种潜在不良药物反应的认识.
主要方法:
- 印度一名40岁男性患者的病例报告.
- 这名患者接受了用于戒酒的氧化治疗.
- 药物管理后24小时内发生的GBFDE.
主要成果:
- 患者在接受氧化后出现了泛型状固定药物喷发.
- 停止氧化和皮质类固醇治疗导致显著改善.
- 这一案例表明,二氧化是GBFDE的潜在触发因素.
结论:
- 二氧化被确定为罕见但可能导致GBFDE的原因.
- 密切监测GBFDE对于那些被处方氧化的患者至关重要.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
643
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
643
Depolarizing Blockers: Pharmocokinetics
567
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
567
Antiepileptic Drugs: Potassium Channel Activators
637
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
637
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
CNS Depressants: Barbiturates and Benzodiazepines
1.2K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.2K
Skeletal Muscle Relaxants: Adverse Effects
776
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
776

